Skip to main content
Journal cover image

The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.

Publication ,  Journal Article
Fulda, ES; Fichtenbaum, CJ; Kileel, EM; Zanni, MV; Aberg, JA; Malvestutto, C; Cardoso, SW; Berzins, B; Lira, R; Harden, R; Robbins, G; Bone, F ...
Published in: Contemp Clin Trials
January 2023

BACKGROUND: REPRIEVE, the Randomized Trial to Prevent Vascular Events in HIV, is a multicenter, primary prevention trial evaluating whether a statin can prevent major cardiovascular events in people with HIV. REPRIEVE is conducted at >100 clinical research sites (CRSs) globally. Detailed, comprehensive, and novel methods for evaluating and communicating CRS performance are required to ensure trial integrity and data quality. In this analysis we describe a comprehensive multidimensional methodology for evaluating CRS performance. METHODS: The REPRIEVE Data Coordinating and Clinical Coordinating Centers developed a robust system for evaluation of and communication with CRSs, designed to identify potential issues and obstacles to performance, provide real-time technical support, and make recommendations for process improvements to facilitate efficient trial execution. We describe these systems and evaluate their impact on participant retention, data management, and specimen management from 2019 to 2022, corresponding to the period from end of recruitment to present. This evaluation was based on pre-defined metrics, regular reviews, and bidirectional communication. RESULTS: Participant retention, data management, and specimen management all remained steady over the three-year period, although metrics varied by country of enrollment. Targeted messaging relating to certain performance metrics was effective. CONCLUSION: Site performance is vital to ensure trial integrity and achievement of key trial goals. This analysis demonstrates that utilization of a comprehensive approach allows for a thorough evaluation of CRS performance, facilitates data and specimen management, and enhances participant retention. Our approach may serve as a guidepost for maximizing future large-scale clinical trials' operational success and scientific rigor. CLINICALTRIALS: gov Identifier: NCT02344290.

Duke Scholars

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

January 2023

Volume

124

Start / End Page

107035

Location

United States

Related Subject Headings

  • Public Health
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • HIV Infections
  • General Clinical Medicine
  • Communication
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fulda, E. S., Fichtenbaum, C. J., Kileel, E. M., Zanni, M. V., Aberg, J. A., Malvestutto, C., … REPRIEVE Investigators. (2023). The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial. Contemp Clin Trials, 124, 107035. https://doi.org/10.1016/j.cct.2022.107035
Fulda, Evelynne S., Carl J. Fichtenbaum, Emma M. Kileel, Markella V. Zanni, Judith A. Aberg, Carlos Malvestutto, Sandra Wagner Cardoso, et al. “The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.Contemp Clin Trials 124 (January 2023): 107035. https://doi.org/10.1016/j.cct.2022.107035.
Fulda ES, Fichtenbaum CJ, Kileel EM, Zanni MV, Aberg JA, Malvestutto C, et al. The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial. Contemp Clin Trials. 2023 Jan;124:107035.
Fulda, Evelynne S., et al. “The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial.Contemp Clin Trials, vol. 124, Jan. 2023, p. 107035. Pubmed, doi:10.1016/j.cct.2022.107035.
Fulda ES, Fichtenbaum CJ, Kileel EM, Zanni MV, Aberg JA, Malvestutto C, Cardoso SW, Berzins B, Lira R, Harden R, Robbins G, Martinez M, Nieves SD, McCallum S, Cruz JL, Umbleja T, Sprenger H, Giguel F, Bone F, Wood K, Byroads M, Paradis K, Lu MT, Douglas PS, Ribaudo HJ, Grinspoon SK, Fitch KV, REPRIEVE Investigators. The importance of methods for site performance evaluation in REPRIEVE, a longitudinal, global, multicenter trial. Contemp Clin Trials. 2023 Jan;124:107035.
Journal cover image

Published In

Contemp Clin Trials

DOI

EISSN

1559-2030

Publication Date

January 2023

Volume

124

Start / End Page

107035

Location

United States

Related Subject Headings

  • Public Health
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • HIV Infections
  • General Clinical Medicine
  • Communication
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences